May 15, 2024
Amsterdam, the Netherlands - Royal Philips (http://www.philips.com/newscenter)
(NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend
for the year 2023 is 1 new common share for every 29.2684 existing common
shares. This ratio was based on the volume weighted average price on Euronext
Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a
manner that the gross dividend in shares will be approximately equal to EUR
0.85. As a result, Philips will issue a total number of 30,860,582 new common
shares.
Distribution of the dividend with delivery of new common shares and settlement
of any fractions in cash, will take place from May 16, 2024. Upon distribution,
the total issued share capital will amount to EUR 188,875,310 representing
944,376,548 common shares.
In the second quarter, Philips intends to cancel 4,437,164 shares that were
acquired under the now completed EUR 1.5 billion share repurchase program for
capital reduction purposes, as announced on July 26, 2021
(https://www.philips.com/a-
w/about/news/archive/corpcomms/news/press/2021/philips-second-quarter-results-
2021.html). Post cancellation, the total number of issued shares will amount to
939,939,384 common shares. More information is available via this l
(https://www.philips.com/a-w/about/investor/stock.html)ink
(https://www.philips.com/a-w/about/investor/stock.html).
For further information, please contact:
Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com (mailto:ben.zwirs@philips.com)
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com (mailto:dorin.danu@philips.com)
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and well-being through meaningful
innovation. Philips' patient- and people-centric innovation leverages advanced
technology and deep clinical and consumer insights to deliver personal health
solutions for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-
guided therapy, monitoring, and enterprise informatics, as well as in personal
health. Philips generated 2023 sales of EUR 18.2 billion and employs
approximately 69,100 employees with sales and services in more than 100
countries. News about Philips can be found at www.philips.com/newscenter
(http://www.philips.com/newscenter).
Forward-looking statements
This release contains certain forward-looking statements with respect to the
financial condition, results of operations and business of Philips and certain
of the plans and objectives of Philips with respect to these items. Examples of
forward-looking statements include statements made about the strategy, estimates
of sales growth, future EBITA, future developments in Philips' organic business
and the completion of acquisitions and divestments. By their nature, these
statements involve risk and uncertainty because they relate to future events and
circumstances and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by these
statements.
Â